AC Immune Valuation
| ACIU Stock | USD 2.42 0.06 2.54% |
Based on Macroaxis valuation methodology, the entity appears to be undervalued. AC Immune owns a latest Real Value of $4.55 per share. The recent price of the entity is $2.42. Our model approximates the value of AC Immune from evaluating the entity fundamentals such as Shares Owned By Insiders of 41.87 %, return on asset of -0.18, and Shares Owned By Institutions of 30.22 % as well as inspecting its technical indicators and probability of bankruptcy. In general, most investors favor acquiring undervalued equities and selling overvalued equities since, sooner or later, asset prices and their ongoing real values will grow together. Key fundamental drivers impacting AC Immune's valuation include:
Price Book 1.546 | Enterprise Value 122.2 M | Enterprise Value Ebitda (3.14) | Price Sales 18.3084 | Enterprise Value Revenue 10.9837 |
Undervalued
Today
Please note that AC Immune's price fluctuation is unstable at this time. Calculation of the real value of AC Immune is based on 3 months time horizon. Increasing AC Immune's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for AC Immune is useful when determining the fair value of the ACIU stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of AC Immune. Since AC Immune is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ACIU Stock. However, AC Immune's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.42 | Real 4.55 | Target 11.08 | Hype 2.11 |
The real value of ACIU Stock, also known as its intrinsic value, is the underlying worth of AC Immune Company, which is reflected in its stock price. It is based on AC Immune's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of AC Immune's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence AC Immune's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of AC Immune helps investors to forecast how ACIU stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AC Immune more accurately as focusing exclusively on AC Immune's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use AC Immune's intrinsic value based on its ongoing forecasts of AC Immune's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against AC Immune's closest peers. When choosing an evaluation method for AC Immune, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
AC Immune Investments |
|
ACIU Valuation Trend
Knowing AC Immune's actual value is paramount for traders to make sound investment determinations. AC Immune's real value is not only important for the investor to make better decisions but also for a more accurate overall view of AC Immune's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both AC Immune's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
ACIU Market Cap
AC Immune is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is presently estimated at about 7.44 Billion. AC Immune holds roughly 233.4 Million in market capitalization claiming about 3% of equities under Health Care industry.AC Immune Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining AC Immune's current stock value. Our valuation model uses many indicators to compare AC Immune value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AC Immune competition to find correlations between indicators driving AC Immune's intrinsic value. More Info.AC Immune is rated below average in price to earning category among related companies. It is rated below average in price to book category among related companies . Price To Book Ratio is likely to drop to 2.11 in 2024. Comparative valuation analysis is a catch-all model that can be used if you cannot value AC Immune by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AC Immune's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AC Immune's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AC Immune's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AC Immune and how it compares across the competition.
About AC Immune Valuation
The stock valuation mechanism determines the current worth of AC Immune on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of AC Immune. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of AC Immune based exclusively on its fundamental and basic technical indicators. By analyzing AC Immune's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of AC Immune's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of AC Immune. We calculate exposure to AC Immune's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to AC Immune's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 14.8 M | 15.5 M | |
| Pretax Profit Margin | (3.66) | (3.85) | |
| Operating Profit Margin | (3.62) | (3.80) | |
| Net Loss | (3.66) | (3.85) | |
| Gross Profit Margin | (16.48) | (15.66) |
8 Steps to conduct AC Immune's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates AC Immune's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct AC Immune's valuation analysis, follow these 8 steps:- Gather financial information: Obtain AC Immune's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine AC Immune's revenue streams: Identify AC Immune's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research AC Immune's industry and market trends, including the size of the market, growth rate, and competition.
- Establish AC Immune's growth potential: Evaluate AC Immune's management, business model, and growth potential.
- Determine AC Immune's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate AC Immune's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
AC Immune Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as AC Immune does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 84.7 M |
AC Immune Current Valuation Indicators
Valuation refers to the process of determining the present value of AC Immune and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value ACIU we look at many different elements of the entity such as ACIU's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. AC Immune's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final AC Immune's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as AC Immune, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use AC Immune's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes AC Immune's worth.When determining whether AC Immune is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ACIU Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Ac Immune Stock. Highlighted below are key reports to facilitate an investment decision about Ac Immune Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AC Immune. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy ACIU Stock please use our How to Invest in AC Immune guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for ACIU Stock analysis
When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is AC Immune's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AC Immune. If investors know ACIU will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AC Immune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.70) | Revenue Per Share 0.175 | Quarterly Revenue Growth 14.8 K | Return On Assets (0.18) | Return On Equity (0.33) |
The market value of AC Immune is measured differently than its book value, which is the value of ACIU that is recorded on the company's balance sheet. Investors also form their own opinion of AC Immune's value that differs from its market value or its book value, called intrinsic value, which is AC Immune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AC Immune's market value can be influenced by many factors that don't directly affect AC Immune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AC Immune's value and its price as these two are different measures arrived at by different means. Investors typically determine if AC Immune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AC Immune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.